Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159).
Marvaso G, Ciardo D, Corrao G, Gandini S, Fodor C, Zerini D, Rojas DP, Augugliaro M, Bonizzi G, Pece S, Cattani F, Mazzocco K, Mistretta FA, Musi G, Alessi S, Petralia G, Pravettoni G, De Cobelli O, Di Fiore PP, Viale G, Orecchia R, Jereczek-Fossa BA.
Marvaso G, et al. Among authors: musi g.
BMC Cancer. 2019 Sep 10;19(1):903. doi: 10.1186/s12885-019-6117-z.
BMC Cancer. 2019.
PMID: 31500605
Free PMC article.